胎盘间充质干细胞经IL-1β促进M2肺泡巨噬细胞而非M1骨髓巨噬细胞改善克雷伯菌ARDS
该研究在气管内感染临床相关肺炎克雷伯菌的致死性小鼠肺炎模型中,评估静脉输注人胎盘间充质干细胞(PMSC)的疗效。PMSC治疗减轻组织损伤并提高生存率,机制为减少募集的M1型骨髓巨噬细胞、保留M2型肺泡巨噬细胞并增强其抗菌功能;PMSC分泌的IL-1β是增强肺泡巨噬细胞抗菌活性、改善病原清除(尤其菌血症)与生存的关键。
要点
- PMSC治疗减轻重症克雷伯菌肺炎小鼠的组织损伤并改善生存。
- PMSC优先保护 resident M2肺泡巨噬细胞,抑制募集的M1骨髓巨噬细胞。
- PMSC分泌的IL-1β增强肺泡巨噬细胞抗菌功能,促进病原清除。
核心结论
- 人PMSC治疗优先保护resident M2肺泡巨噬细胞而非募集的M1骨髓巨噬细胞,总体向M2极化,从而改善克雷伯菌相关ARDS的生存。
研究设计与样本
- 致死性小鼠肺炎模型:气管内感染临床相关肺炎克雷伯菌株,随后静脉输注人PMSC。
- 评估肺内肺泡巨噬细胞与募集的骨髓巨噬细胞、组织学、细菌清除及小鼠生存。
- 采用气管内氯膦酸盐预处理清除肺泡巨噬细胞,以明确resident肺泡巨噬细胞的作用。
主要发现
- PMSC治疗减少组织损伤并改善重症克雷伯菌肺炎小鼠生存。
- PMSC治疗降低募集的M1型骨髓巨噬细胞的存在与功能,同时保留M2型肺泡巨噬细胞并增强其抗菌功能。
- PMSC治疗未能挽救肺泡巨噬细胞被清除的克雷伯菌肺炎小鼠。
- PMSC分泌的IL-1β被确定为增强肺泡巨噬细胞抗菌活性、显著改善病原清除(尤其菌血症)与生存的关键。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Acute respiratory distress syndrome (ARDS) is a lethal complication of severe bacterial pneumonia due to the inability to dampen overexuberant immune responses without compromising pathogen clearance. Both of these processes involve tissue-resident and bone marrow (BM)-recruited macrophage (MΦ) populations which can be polarised to have divergent functions. Surprisingly, despite the known immunomodulatory properties of mesenchymal stem cells (MSCs), simultaneous interactions with tissue-resident and recruited BMMΦ populations are largely unexplored. OBJECTIVES: We assessed the therapeutic use of human placental MSCs (PMSCs) in severe bacterial pneumonia with elucidation of the roles of resident alveolar MΦs (AMΦs) and BMMΦs. METHODS: We developed a lethal, murine pneumonia model using intratracheal infection of a clinically relevant Klebsiella pneumoniae (KP) strain with subsequent intravenous human PMSC treatment. Pulmonary AMΦ and recruited BMMΦ analyses, histological evaluation, bacterial clearance and mice survival were assessed. To elucidate the role of resident AMΦs in improving outcome, we performed AMΦ depletion in the KP-pneumonia model with intratracheal clodronate pretreatment. MEASUREMENTS AND MAIN RESULTS: Human PMSC treatment decreased tissue injury and improved survival of severe KP-pneumonia mice by decreasing the presence and function of recruited M1 BMMΦ while preserving M2 AMΦs and enhancing their antibacterial functions. Interestingly, PMSC therapy failed to rescue AMΦ-depleted mice with KP pneumonia, and PMSC-secreted IL-1β was identified as critical in increasing AMΦ antibacterial activities to significantly improve pathogen clearance-especially bacteraemia-and survival. CONCLUSIONS: Human PMSC treatment preferentially rescued resident M2 AMΦs over recruited M1 BMMΦs with overall M2 polarisation to improve KP-related ARDS survival.
引用
- Wang LT, Yen BL, Wang HH, et al. Placental mesenchymal stem cells boost M2 alveolar over M1 bone marrow macrophages via IL-1β in Klebsiella-mediated acute respiratory distress syndrome. Thorax. 2022. PMID: 35450943. doi:10.1136/thoraxjnl-2021-217928
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。